Monday, November 26, 2018, Rockville, Maryland. There are many factors that influence the aging process. Unlocking these factors can lead to valuable insights into what impacts the condition and health of the human body and reveal how to minimize these impacts. Researchers from Haut.AI, a machine vision and artificial intelligence for skin care company, in collaboration with Insilico Medicine have developed a simple and accurate predictor of chronological age called the PhotoAgeClock. These findings resulted in a research paper titled, "PhotoAgeClock: deep learning algorithms for development of non-invasive visual biomarkers of aging," published in Aging (Albany, NY), one of the leading journals in aging research.
"We are very happy to collaborate with one of the most innovative, global, and ethical consumer companies committed to benefit consumers around the world on this important artificial intelligence project. The future of consumer business is in personalization and I hope that this study will lay the foundation for AI-powered consumer skincare and healthcare. Skin is our largest and one of the most important organs. Understanding the many biological processes in skin using AI may lead to the many breakthroughs down the road," said Anastasia Georgievskaya, CEO of Haut AI, an Estonia-based artificial intelligence company.
The results of the study demonstrate that the most accurate, non-invasive biomarker for biological age prediction is the skin around the corners of the eye. The photographic aging clock uses recent advances in Artificial Intelligence (AI) to predict age with 2.3 years Mean Absolute Error (MAE).
The study used 8,414 anonymized high-resolution left and right eye corner photos to demonstrate that it is possible to achieve high quality age estimations from a small facial region. It was found that, specifically, the eye corner and eyelid areas had the most significant impact on age prediction. As a result of this research, it is now possible to develop anonymized systems for age prediction using only photographs of corners of the eye. This information can be used in the development of personalized medical interventions and skin care treatments for aging. Highly-accurate predictors of chronological age can also be used to evaluate the impact that various lifestyle, medical, and cosmetic interventions have on aging.
These recent findings also illustrate that the revolution in AI-powered aging clocks is well underway, and it will soon be possible to measure the rate of aging at every level. This research can also have far-reaching impacts when applied to biologically-relevant data in the study of many other imaging data types, transcriptomics, proteomics, extracellular matrix readouts, and readouts of smart sensors installed in clothing and wearables.
"Deep neural networks are often perceived as the black boxes; however, this is a common misconception. Aging research helps make DNNs more interpretable. This study shows what area of the face is most important for age estimation but when you do it on other data types like gene or protein expression, it is possible to see what genes are more important and construct the causal networks. I personally believe that the AI aging clocks are among the most important breakthroughs in longevity biotechnology and we will see the many advances resulting from similar studies. As for this study, you may want to take care of the eye corners if you want to look younger to some of the age predictors, said Alex Zhavoronkov, PhD, CEO of Insilico Medicine.
Haut.AI, the world's leader in photographic aging clocks and personalized AI-driven skincare has many academic and industry collaborations. It is massively-collaborative and the team is interested in any partnership that results in great science and novel insights into skin health.
Please follow the link below to read the article: https://www.aging-us.com/article/101629/text
HautAI specializes in the photographic biomarkers of aging, skin health, and direct to consumer personalized skin care.
Insilico Medicine is regularly publishing research papers in peer-reviewed journals. The company was first to apply the generative adversarial networks (GANs) to the generation of the new molecular structures with the specified parameters and published a seminal peer-reviewed paper submitted in June 2016. The concept was further extended and augmented with advanced memory and reinforcement learning. One of the latest papers published in the Journals of Gerontology demonstrated the application of the deep neural networks to assessing the biological age of the patients. The latest special issue in Molecular Pharmaceutics featured several research papers by Insilico Medicine.
For further information, images or interviews, please contact:
About Insilico Medicine, Inc
Insilico Medicine is an artificial intelligence company headquartered in Rockville, with R&D and management resources in Belgium, Russia, UK, Taiwan, and Korea sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research. Insilico pioneered the applications of the generative adversarial networks (GANs) and reinforcement learning for generation of novel molecular structures for the diseases with a known target and with no known targets. In addition to working collaborations with the large pharmaceutical companies, the company is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with LifeExtension.com, the company launched a range of nutraceutical products compounded using the advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI.
In 2017, NVIDIA selected Insilico Medicine as one of the Top 5 AI companies in its potential for social impact. In 2018, the company was named one of the global top 100 AI companies by CB Insights. In 2018 it received the Frost & Sullivan 2018 North American Artificial Intelligence for Aging Research and Drug Development Award accompanied with the industry brief. Brief company video: https://www.youtube.com/watch?v=l62jlwgL3v8. http://www.insilico.com Website: http://insilico.com/